bioAffinity Technologies, Inc. (BIAF) vs IceCure Medical Ltd (ICCM)
A side-by-side comparison of bioAffinity Technologies, Inc. and IceCure Medical Ltd across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BIAF
bioAffinity Technologies, Inc.
$6.07HealthcareDelayed quote: Oct 6, 2026, 2:59 PM EDT
ICCM
IceCure Medical Ltd
$1.40HealthcareDelayed quote: Oct 6, 2026, 3:00 PM EDT
Total return — BIAF vs ICCM
growth of $100 · dividends reinvested · last 4yBIAF -99.8% (-79.8%/yr)ICCM -96.9% (-58.0%/yr)ICCM compounded faster over this window
Log scale — wide-divergence pair
BIAF ICCM
BIAF vs ICCM: by the numbers
- •ICCM is the larger company ($3M vs $3M market cap).
- •Both run net losses; BIAF's is the smaller (-257.33% vs -427.67% net margin).
Metrics side by side
Valuation
| Metric | BIAF | ICCM |
|---|---|---|
| P/S ratio | 0.43 | 0.80 |
| P/B ratio | 0.67 | 0.27 |
Profitability
| Metric | BIAF | ICCM |
|---|---|---|
| Gross margin | 23.21% | 36.10% |
| Operating margin | -171.58% | -446.70% |
| Net margin | -257.33% | -427.67% |
| ROE | -402.92% | -141.90% |
| ROIC | -237.93% | -184.27% |
Growth (annualized)
| Metric | BIAF | ICCM |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -0.69% |
| Total return CAGR (5Y) | N/A | -63.05% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.